Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.

J Asthma Allergy · 2009 · PMC3048600 · PMID 21437146

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantP < 0.01actually significant

After 7 days’ treatment with ebastine 20 mg, skin prick tests with allergens revealed a highly significant ( P < 0.01) inhibition of the wheal surface area at 6 hours, 24 hours, and 2 days after treatment compared with placebo.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.